The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors.
Saved in:
| Title: | The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors. |
|---|---|
| Authors: | Bissonnette RP; HUYABIO International, LLC, San Diego, CA, USA., Cesario RM; HUYABIO International, LLC, San Diego, CA, USA., Goodenow B; HUYABIO International, LLC, San Diego, CA, USA., Shojaei F; HUYABIO International, LLC, San Diego, CA, USA. fshojaei@huyabio.com., Gillings M; HUYABIO International, LLC, San Diego, CA, USA. |
| Source: | BMC cancer [BMC Cancer] 2021 Aug 30; Vol. 21 (1), pp. 969. Date of Electronic Publication: 2021 Aug 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
